UnitedHealth Group (UNH) Set to Announce Quarterly Earnings on Tuesday

Key Points

• UnitedHealth Group is scheduled to report Q3 2026 results before the market opens Tuesday, October 13. Analysts expect earnings of $4.12 per share and revenue of approximately $111.3 billion; the company’s full-year EPS guidance is $19.50–$20.00.
• In its latest quarter, UnitedHealth earned $6.38 per share, exceeding estimates by $1.44, while revenue rose 0.4% year over year to $112.03 billion.
• Wall Street maintains a “Moderate Buy” consensus, with 20 analysts rating the stock a Buy and eight rating it a Hold; the average price target is $465.75 versus a recent share price of $378.70.

UnitedHealth Group (NYSE:UNH - Get Free Report) is expected to issue its Q3 2026 results before the market opens on Tuesday, October 13th. Analysts expect the company to post earnings of $4.12 per share and revenue of $111.3112 billion for the quarter. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. Interested persons may visit the the company's upcoming Q3 2026 earning results page for the latest details on the call scheduled for Tuesday, October 13, 2026 at 8:00 AM ET.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings results on Thursday, July 16th. The healthcare conglomerate reported $6.38 earnings per share for the quarter, topping the consensus estimate of $4.94 by $1.44. UnitedHealth Group had a net margin of 3.14% and a return on equity of 16.53%. The firm had revenue of $112.03 billion for the quarter, compared to the consensus estimate of $110.81 billion. During the same period last year, the firm posted $4.08 earnings per share. The company's revenue for the quarter was up .4% on a year-over-year basis. On average, analysts expect UnitedHealth Group to post $20 EPS for the current fiscal year and $23 EPS for the next fiscal year.

UnitedHealth Group Stock Up 1.8%

Shares of NYSE UNH opened at $378.70 on Tuesday. The company has a current ratio of 0.78, a quick ratio of 0.78 and a debt-to-equity ratio of 0.66. The company has a 50-day moving average of $392.50 and a 200 day moving average of $378.32. UnitedHealth Group has a 12-month low of $255.96 and a 12-month high of $461.62. The stock has a market cap of $339.92 billion, a PE ratio of 24.37, a P/E/G ratio of 1.40 and a beta of 0.60.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 22nd. Investors of record on Monday, September 14th were issued a $2.32 dividend. This represents a $9.28 annualized dividend and a dividend yield of 2.5%. The ex-dividend date of this dividend was Monday, September 14th. UnitedHealth Group's dividend payout ratio (DPR) is currently 59.72%.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, CEO Patrick Conway sold 1,169 shares of UnitedHealth Group stock in a transaction dated Friday, August 21st. The shares were sold at an average price of $390.00, for a total transaction of $455,910.00. Following the completion of the sale, the chief executive officer directly owned 15,328 shares in the company, valued at $5,977,920. This trade represents a 7.09% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 0.19% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of equities analysts have weighed in on the company. Oppenheimer boosted their price objective on UnitedHealth Group from $420.00 to $500.00 and gave the stock an "outperform" rating in a research note on Friday, July 17th. Robert W. Baird raised shares of UnitedHealth Group from an "underperform" rating to a "neutral" rating and boosted their price target for the company from $287.00 to $453.00 in a research report on Thursday, July 16th. Mizuho raised their price objective on shares of UnitedHealth Group from $470.00 to $493.00 and gave the stock an "outperform" rating in a research report on Monday, July 20th. Zacks Research lowered shares of UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a report on Monday, September 14th. Finally, Cantor Fitzgerald raised their price target on shares of UnitedHealth Group from $440.00 to $495.00 and gave the stock an "overweight" rating in a report on Friday, July 17th. Twenty equities research analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the stock. According to data from MarketBeat.com, UnitedHealth Group presently has a consensus rating of "Moderate Buy" and an average price target of $465.75.

About UnitedHealth Group

UnitedHealth Group Incorporated NYSE: UNH is a diversified health care and well-being company serving individuals, employers, health care providers and government programs. Its operations are organized primarily through UnitedHealthcare and Optum.

UnitedHealthcare provides health benefit plans and services, including employer-sponsored coverage, individual and family plans, Medicare and Medicaid offerings, and other government-supported programs. Its services include health insurance administration, pharmacy benefits and care management.

Optum provides health care services, technology and data solutions, pharmacy services, and analytics to health plans, employers, government agencies, health care providers and consumers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.